APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 51 filers reported holding APTEVO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $354,000 | +11.0% | 540,057 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $319,000 | -43.0% | 540,057 | -14.6% | 0.00% | -66.7% |
| Q2 2019 | $560,000 | +305.8% | 632,507 | +312.8% | 0.00% | +200.0% |
| Q1 2019 | $138,000 | -76.5% | 153,229 | -66.9% | 0.00% | -66.7% |
| Q4 2018 | $587,000 | -73.8% | 462,824 | +4.8% | 0.00% | -66.7% |
| Q3 2018 | $2,244,000 | +22.4% | 441,765 | +20.2% | 0.01% | +12.5% |
| Q2 2018 | $1,833,000 | +173.2% | 367,509 | +79.0% | 0.01% | +166.7% |
| Q1 2018 | $671,000 | +133.8% | 205,291 | +202.8% | 0.00% | +200.0% |
| Q4 2017 | $287,000 | +245.8% | 67,799 | +87.2% | 0.00% | – |
| Q3 2017 | $83,000 | +31.7% | 36,221 | +18.3% | 0.00% | – |
| Q2 2017 | $63,000 | +50.0% | 30,609 | +50.8% | 0.00% | – |
| Q1 2017 | $42,000 | -77.7% | 20,304 | -73.7% | 0.00% | -100.0% |
| Q4 2016 | $188,000 | -85.2% | 77,071 | -84.4% | 0.00% | -83.3% |
| Q3 2016 | $1,266,000 | – | 494,393 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 974,492 | $2,495,000 | 0.55% |
| Perceptive Advisors | 988,133 | $2,530,000 | 0.16% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 38,860 | $99,000 | 0.07% |
| Laurel Wealth Advisors, Inc. | 42,890 | $110,000 | 0.05% |
| CSS LLC/IL | 353,977 | $906,000 | 0.04% |
| GLG Partners LP | 396,486 | $1,015,000 | 0.03% |
| Capital Impact Advisors, LLC | 12,318 | $32,000 | 0.01% |
| Spark Investment Management LLC | 66,000 | $168,000 | 0.01% |
| Peak Asset Management, LLC | 10,000 | $26,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 99,390 | $254,000 | 0.01% |